Background: Delirium occurs frequently in patients with chronic obstructive pulmonary disease(COPD) in the intensive care unit(ICU).Effective prevention and treatment strategies for delirium remain limited. We aimed to assess delirium and 30-day mortality in patients with COPD who were statin and non-statin users.
Methods: In this retrospective study,patients with COPD were identified from the Medical Information Mart for Intensive Care database(MIMIC-IV).The primary exposure variable was the use of statins 3 days after entering the ICU and the primary outcome measure was the presence of delirium. The secondary outcome measure was 30-day mortality. Since the cohort study was retrospective, we used an inverse probability weighting derived from the propensity score matching to balance different variables.
Results: Among a cohort of 2738 patients, 1493 (55%) were statin users. Before propensity score matching, the prevalence of delirium was 16% and the 30-day mortality was 18% in patients with COPD. Statin use was significantly negatively correlated with delirium, with an odds ratio of 0.69 (95% CI,0.56~0.84, P < 0.001) in the inverse probability weighted cohort and 30-day mortality of 0.7 (95% CI,0.58~0.85, P < 0.001).
Conclusions: Statins administered in the ICU can significantly reduce the incidence of delirium and 30-day mortality in patients with COPD.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.